PROF: Profound Medical Corp. Common Stock Company Profile & Statistics

Profound Medical Corp. Common Stock Profile

About

Profound Medical Corp. is a medical technology company. It is focused on a therapeutics platform which provides the precision of real-time Magnetic Resonance Imaging technology for the incision-free ablation of diseased tissue. The company principally commercialized the TULSA-PRO(R) and Sonalleve(R) platforms. Profound Medical Corp. is based in Mississauga, Canada.

Info & Links

CEO

Arun Menawats

Headquarters

2400 SKYMARK AVENUE, UNIT 6
MISSISSAUGA, A6 L4W 5K5, CANADA

Auditor

PricewaterhouseCoopers LLP

Share holders

8,364

Employees

142

Profound Medical Corp. Common Stock Statistics

Valuation Measures

Market Capitalization²

183.02M

Enterprise Value

152.29M

Enterprise Value/EBITDA(ttm)

-3.66

Price to Earnings Ratio(ttm)

Price to Sales(ttm)

15.81

Price to Book(mrq)

4.75

Price to Cash(ytd)

Profitability

Gross Margin(ttm)

69.54%

Operating Margin(ttm)

-343.97%

Profit Margin(ttm)

-392.04%

Return on Equity(ttm)

-89.74%

Return on Invested Capital(ttm)

-90.28%

Return on Assets(ttm)

-73.06%

Income Statement

Revenue(ttm)

11.84M

Revenue Per Share(ttm)

0.39

Gross Profit(ttm)

8.22M

EBITDA(ttm)³

-41.56M

Net Income Available to Common(ttm)

-40.73M

Diluted EPS(ttm)

-1.46

Share Statistics

Beta (5Y Monthly)

0.66

52-Week Change

-17.55%

S&P 500 52-Week Change

19.58%

S&P 500 Member

Yes

Stock Optionable

Yes

Total Shares Outstanding¹

30.05M

Dividend Yield

0.00%

Float⁴

29.73M

% Held by Insiders

1.52%

% Held by Institutions

47.86%

Balance Sheet

Total Cash(mrq)

35.20M

Total Cash Per Share(mrq)

1.17

Total Debt(mrq)

4.46M

Total Debt/Equity(mrq)

11.37%

Current Ratio(mrq)

8.53%

Quick Ratio(mrq)

7.07%

Book Value Per Share(mrq)

1.31

Cash Flow

Operating Cash Flow Per Share(ytd)

-0.73

Free Cash Flow(ytd)

-22.03M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.

1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
2 Market Cap is calculated using total shares outstanding and the most recent share price.
3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.

PROF

Profound Medical Corp. Common Stock